April 22, 2025
Update: LCD L39756 – Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers
The effective date for Local Coverage Determination (LCD) L39756 – Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers, and its associated Billing and Coding Article (A59618), is postponed until January 1, 2026.
In the interim, you may send high-quality peer-reviewed published literature on this topic to CAGInquiries@cms.hhs.gov by November 1, 2025. For further information on the quality of literature, see Principles of Study Design.
Reference: CMS Statement on Local Coverage Determination for Certain Skin Substitute Grafts | CMS